Home › NDC Lookup › RxCUI directory › RxCUI 2712088

5 ML efgartigimod alfa-qvfc 200 MG/ML / hyaluronidase-qvfc 2000 UNT/ML Prefilled Syringe [... — RxCUI 2712088

Name: 5 ML efgartigimod alfa-qvfc 200 MG/ML / hyaluronidase-qvfc 2000 UNT/ML Prefilled Syri… (RxCUI 2712088)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 2712088 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2712088

Official name5 ML efgartigimod alfa-qvfc 200 MG/ML / hyaluronidase-qvfc 2000 UNT/ML Prefilled Syringe [Vyvgart Hytrulo]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asVyvgart Hytrulo (efgartigimod alfa-hyaluronidase-qvfc 1,000 MG / 10,000 UNT) per 5 ML Prefilled Syringe; VYVGART Hytrulo 1,000 MG / 10,000 UNT in 5 ML Prefilled Syringe

FDA products mapped2

Package NDCs mapped3

Reported Medicaid activity (SDUD)2,063 prescriptions · 26 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

🕸️ Concept Web — How 5 ML efgartigimod alfa-qvfc 200 MG/ML / hyaluron... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 5 ML efgartigimod alfa-qvfc 200 MG/ML / hyaluronidase-qvfc 2000 UNT/ML Prefilled Syringe [Vyvgart Hytrulo] RxCUI 2712088 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 5

The active substance itself — no strength, form, or brand attached yet.
- Efgartigimod alfa 2587717 IN
- Hyaluronidase 5464 IN
- Efgartigimod alfa / hyaluronidase 2639948 MIN
- Efgartigimod alfa-qvfc 2639944 PIN
- Hyaluronidase-qvfc 2639946 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Vyvgart Hytrulo 2639953 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Efgartigimod alfa / hyaluronidase Prefilled Syringe 2712081 SCDF
- Efgartigimod alfa-qvfc / hyaluronidase-qvfc Prefilled Syringe 2712082 SCDFP
- Efgartigimod alfa / hyaluronidase Injectable Product 2639949 SCDG
- Efgartigimod alfa-qvfc / hyaluronidase-qvfc Injectable Product 2662922 SCDGP
- Efgartigimod alfa / hyaluronidase Prefilled Syringe [Vyvgart Hytrulo] 2712086 SBDF
- Efgartigimod alfa-qvfc / hyaluronidase-qvfc Prefilled Syringe [Vyvgart Hytrulo] 2712087 SBDFP
- Vyvgart Hytrulo Injectable Product 2639955 SBDG
- Prefilled Syringe 721656 DF
- +1 more in this family
Clinical & branded drugs 4

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- 5 ML efgartigimod alfa-qvfc 200 MG/ML / hyaluronidase-qvfc 2000 UNT/ML Prefilled Syringe 2712083 SCD
- Efgartigimod alfa-qvfc 200 MG/ML 2712080 SCDC
- Hyaluronidase-qvfc 2000 UNT/ML 2639947 SCDC
- Efgartigimod alfa-qvfc 200 MG/ML / hyaluronidase-qvfc 2000 UNT/ML [Vyvgart Hytrulo] 2712085 SBDC

Showing up to 8 concepts per family — 18 of 19 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

5 ML efgartigimod alfa-qvfc 200 MG/ML / hyaluronidase-qvfc 2000 UNT/ML Prefilled Syringe SCD · 2712083
Efgartigimod alfa-qvfc 200 MG/ML SCDC · 2712080
Hyaluronidase-qvfc 2000 UNT/ML SCDC · 2639947
Efgartigimod alfa / hyaluronidase Prefilled Syringe SCDF · 2712081
Efgartigimod alfa-qvfc / hyaluronidase-qvfc Prefilled Syringe SCDFP · 2712082
Efgartigimod alfa / hyaluronidase Injectable Product SCDG · 2639949
Efgartigimod alfa-qvfc / hyaluronidase-qvfc Injectable Product SCDGP · 2662922

Brand-Name Concepts

Efgartigimod alfa-qvfc 200 MG/ML / hyaluronidase-qvfc 2000 UNT/ML [Vyvgart Hytrulo] SBDC · 2712085
Efgartigimod alfa / hyaluronidase Prefilled Syringe [Vyvgart Hytrulo] SBDF · 2712086
Efgartigimod alfa-qvfc / hyaluronidase-qvfc Prefilled Syringe [Vyvgart Hytrulo] SBDFP · 2712087
Vyvgart Hytrulo Injectable Product SBDG · 2639955
Vyvgart Hytrulo BN · 2639953

📦 FDA Products & Package NDCs

2 products · 3 package NDCs

3 package NDCs map to RxCUI 2712088 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
73475-1221-01	1 SYRINGE, GLASS in 1 CARTON (73475-1221-1) / 5 mL in 1 SYR...	VYVGART Hytrulo	argenx US	2025-04-10
73475-1221-04	4 SYRINGE, GLASS in 1 CARTON (73475-1221-4) / 5 mL in 1 SYR...	VYVGART Hytrulo	argenx US	2025-04-10
73475-3102-03	1 VIAL, SINGLE-DOSE in 1 CARTON (73475-3102-3) / 5.6 mL in...	VYVGART Hytrulo	argenx US	2023-06-20

Observed labelers: argenx US (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J9334	Inj efgart-alfa 2mg hya-qvfc	3	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.